279 related articles for article (PubMed ID: 33760186)
1. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
2. SPAG5, the upstream protein of Wnt and the target of curcumin, inhibits hepatocellular carcinoma.
Li H; Qin Y; Huang Y; Wang J; Ren B
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37539742
[TBL] [Abstract][Full Text] [Related]
3. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
[TBL] [Abstract][Full Text] [Related]
4. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Jiang J; Li Y; Jiang Z
Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
[TBL] [Abstract][Full Text] [Related]
5. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
Qian C; Liu Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
[TBL] [Abstract][Full Text] [Related]
6. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
Yang B; Zhao J; Huo T; Zhang M; Wu X
J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
8. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
9. SAC3D1 activates Wnt/β‑catenin signalling in hepatocellular carcinoma.
Wang H; Shi X
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004462
[TBL] [Abstract][Full Text] [Related]
10. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
11. Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway.
Xia J; Zhu Z; Wen G; Chen Y; An R; Xia S; Guan W; Ren H
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37350415
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
Yang Q; Zhuge X; Lin W; Yu W; Zhu Y; Shi C; Shi Z
Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
[TBL] [Abstract][Full Text] [Related]
13. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
Bai Z; Xia X; Lu J
Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.
Li C; Wang Z; Chen S; Zhang J; Qu K; Liu C
Int J Mol Med; 2018 Dec; 42(6):3309-3317. PubMed ID: 30221686
[TBL] [Abstract][Full Text] [Related]
17. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
[TBL] [Abstract][Full Text] [Related]
18. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma.
Guo L; Chen H; Chen J; Gao C; Fu X; Zhou S; Wu W; Li T; Lin J; Yang T; Chen Z; Cao L
Tissue Cell; 2023 Jun; 82():102083. PubMed ID: 37054536
[TBL] [Abstract][Full Text] [Related]
19. SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway.
Lan R; Yu Y; Song J; Xue M; Gong H
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38426532
[TBL] [Abstract][Full Text] [Related]
20. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
